Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sales of blood purification products for hemadsorption field in worldwide. The company provides solutions for ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, kidney, and liver diseases. It offers HA series hemoperfusion cartridge, BS series bilirubin adsorption column and DNA immunoadsorption column, hemoperfusion machine, and blood purification machine; and other products, such as hemodialyzer, disinfectants, hemodialysis concentrate, resin bandages, online hemodialysis powder bag/bucket, and adsorbable suture with needles, as well as syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Metrics to compare | 300529 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300529PeersSector | |
---|---|---|---|---|
P/E Ratio | 25.2x | 26.6x | −0.5x | |
PEG Ratio | 0.62 | 0.44 | 0.00 | |
Price/Book | 5.2x | 2.1x | 2.6x | |
Price / LTM Sales | 7.4x | 7.2x | 3.3x | |
Upside (Analyst Target) | 23.3% | 27.1% | 45.1% | |
Fair Value Upside | Unlock | 14.9% | 7.4% | Unlock |